FI
Fosun International Portfolio holdings
AUM
$360M
1-Year Return
38.28%
This Quarter Return
-18.56%
1 Year Return
+38.28%
3 Year Return
+3.77%
5 Year Return
+27.59%
10 Year Return
+94.55%
AUM
$1.67B
AUM Growth
-$412M
(-20%)
Cap. Flow
+$50M
Cap. Flow
% of AUM
2.99%
Top 10 Holdings %
Top 10 Hldgs %
54.47%
Holding
343
New
97
Increased
69
Reduced
59
Closed
44
Top Buys
| 1 |
Vipshop
VIPS
|
$16.5M |
| 2 |
SDRL
Seadrill Limited Common Stock
SDRL
|
$14.4M |
| 3 |
DigitalBridge
DBRG
|
$12.9M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$10.5M |
| 5 |
MakeMyTrip
MMYT
|
$5.07M |
Top Sells
| 1 |
Brookdale Senior Living
BKD
|
$46M |
| 2 |
Bath & Body Works
BBWI
|
$18.6M |
| 3 |
Bilibili
BILI
|
$13M |
| 4 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
$10.8M |
| 5 |
Gilead Sciences
GILD
|
$9.52M |
Sector Composition
| 1 | Healthcare | 39.38% |
| 2 | Financials | 7.66% |
| 3 | Consumer Discretionary | 5.31% |
| 4 | Communication Services | 3.82% |
| 5 | Industrials | 2.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
T-Mobile US
TMUS
$284B
| $814K | 0.05% |
13,000
-14,000
| -52% | -$877K |
|
152
Vertex Pharmaceuticals
VRTX
$102B
| $812K | 0.05% |
5,000
| – | – |
|
153
MEI Pharma
MEIP
$140M
| $801K | 0.05% |
+19,826
| New | +$801K |
|
154
McDonald's
MCD
$226B
| $799K | 0.05% |
4,550
+1,500
| +49% | +$263K |
|
155
Protalix BioTherapeutics
PLX
$127M
| $795K | 0.05% |
263,140
| – | – |
|
156
Linde
LIN
$222B
| $794K | 0.05% |
+5,174
| New | +$794K |
|
157
Expeditors International
EXPD
$16.5B
| $791K | 0.05% |
+11,800
| New | +$791K |
|
158
GE Aerospace
GE
$299B
| $785K | 0.05% |
22,536
+4,800
| +27% | +$167K |
|
159
Charles Schwab
SCHW
$177B
| $780K | 0.05% |
19,000
| – | – |
|
160
Rhythm Pharmaceuticals
RYTM
$6.95B
| $779K | 0.05% |
+29,720
| New | +$779K |
|
161
Spyre Therapeutics
SYRE
$1.03B
| $778K | 0.05% |
+3,886
| New | +$778K |
|
162
Assurant
AIZ
$10.9B
| $765K | 0.05% |
8,700
| – | – |
|
163
APA Corp
APA
$8.39B
| $749K | 0.04% |
28,000
+3,000
| +12% | +$80.3K |
|
164
Newmont
NEM
$82.3B
| $742K | 0.04% |
21,200
+12,000
| +130% | +$420K |
|
165
Assembly Biosciences
ASMB
$179M
| $737K | 0.04% |
+2,833
| New | +$737K |
|
166
Under Armour
UAA
$2.26B
| $716K | 0.04% |
+40,000
| New | +$716K |
|
167
International Flavors & Fragrances
IFF
$16.8B
| $715K | 0.04% |
5,400
+1,500
| +38% | +$199K |
|
168
Talphera
TLPH
$10.6M
| $709K | 0.04% |
15,085
-8,867
| -37% | -$417K |
|
169
Qualcomm
QCOM
$172B
| $690K | 0.04% |
12,300
| – | – |
|
170
Cintas
CTAS
$83.4B
| $686K | 0.04% |
16,400
| – | – |
|
171
Agilent Technologies
A
$36.4B
| $675K | 0.04% |
10,160
| – | – |
|
172
IBM
IBM
$230B
| $673K | 0.04% |
6,187
+539
| +10% | +$58.6K |
|
173
Teva Pharmaceuticals
TEVA
$21.2B
| $666K | 0.04% |
43,000
| – | – |
|
174
Cidara Therapeutics
CDTX
$1.65B
| $659K | 0.04% |
15,334
| – | – |
|
175
Oracle
ORCL
$626B
| $659K | 0.04% |
14,655
-24,000
| -62% | -$1.08M |
|